Skip to main content

Nasdaq IPOs

Technology SPAC dMY Technology Group prices IPO at $10

6 years 7 months ago
dMY Technology Group, a blank check company targeting a consumer internet or mobile app business, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of one warrant exercisable at $11.50.  dMY Te
Renaissance Capital

Deepwater E&P EnVen Energy withdraws estimated $300 million IPO

6 years 7 months ago
EnVen Energy, an E&P focused on deepwater oil projects in the Gulf of Mexico, withdrew its plans for an initial public offering on Wednesday. It had originally filed to raise an estimated $300 million in October 2018 and last updated its filing in April 2019. The Houston
Renaissance Capital

Preclinical biotech Passage Bio sets terms for $126 million IPO

6 years 7 months ago
Passage Bio, a preclinical biotech developing gene therapies for rare CNS disorders, announced terms for its IPO on Tuesday. The Philadelphia, PA-based company plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint of the propo
Renaissance Capital

US IPO Week Ahead: IPO market slows during short holiday week

6 years 7 months ago
There are no companies scheduled to price next week, though two micro-cap IPOs may price on a day-to-day basis: Chinese healthcare training platform Zhongchao (ZCMD) and flooring roll-up F5 Finishes (FLRZ). A number of IPOs may launch on Tuesday, inclu
Renaissance Capital

US IPO Weekly Recap: The year's busiest slow week?

6 years 7 months ago
Six companies and five SPACs entered the public market raising about $2 billion. The week's deals mostly included uplistings, crosslistings, and micro-caps, with biotech Revolution Medicines (RVMD) soaring in the standout IPO of the week. Luxury shoemaker&n
Renaissance Capital

Healthcare SPAC LifeSci Acquisition sets terms for $50 million IPO

6 years 7 months ago
LifeSci Acquisition, a blank check company targeting healthcare industry, announced terms for its IPO on Friday. The New York, NY-based company plans to raise $50 million by offering 5 million units at a price of $10 and would command a market value of $63 million. Each unit con
Renaissance Capital

Genetic disorder biotech Imara files for an $86 million IPO

6 years 7 months ago
Imara, a Phase 2 biotech developing small molecule therapies for rare genetic disorders, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Boston, MA-based company was founded in 2016 and plans to list on the Nasdaq under the symbol IMRA.
Renaissance Capital

Fortive spin out Vontier files for an estimated $1 billion IPO

6 years 7 months ago
Vontier, a carve-out of Fortive's mobility infrastructure services unit, filed on Friday with the SEC to raise up to $100 million in an initial public offering, though we estimate the offering may be closer to $1 billion. The Raleigh, NC-based company was founded in 2019 and boo
Renaissance Capital

Shoemaker Cole Haan files for an estimated $200 million IPO

6 years 7 months ago
Cole Haan, a premium manufacturer of shoes and other luxury accessories, filed on Friday with the SEC to raise up to $100 million in an initial public offering.  However, the deal size is likely a placeholder for an IPO that we estimate could raise $200 million
Renaissance Capital

Nano-cap restaurant chain Muscle Maker prices $8 million IPO at $5

6 years 7 months ago
Muscle Maker, a healthy fast casual restaurant chain with 39 mostly-franchised stores, raised $8 million by offering 1.5 million shares at $5. Muscle Maker plans to list on the Nasdaq under the symbol GRIL. Alexander Capital acted as a lead manager on the deal. &nbs
Renaissance Capital
Checked
28 minutes 29 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed